Results from Arm A of Phase 1/2 DREAMM-6 trial: belantamab mafodotin with lenalidomide plus dexamethasone in patients with relapsed/refractory multiple myeloma

• 期刊论文

• 出版模式：

  开放获取

• 发表日期：

  2024年10月21日

• Rakesh Popat,
• Bradley Augustson,
• Mercedes Gironella,
• Cindy Lee,
• Paul Cannell,
• Nashita Patel,
• Ravi S. Kasinathan,
• Rachel Rogers,
• Mehreen Shaikh,
• Amy Curry,
• Fernando Carreño,
• Sumita Roy-Ghanta,
• Joanna Opalinska,
• Hang Quach